TCL Archive Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies September 25, 1998
TCL Archive Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds April 13, 2012
TCL Archive FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI April 15, 1977
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Centers Settle Into New Home, Face Old Problem; Five May Lose Grants, No Reprogramming Seen November 17, 1989
